Share
|
Copy Link
https://eyewire.news/tv/eyewire-tv-september-7th-2022
https://eyewire.news/tv/iveric-bio-reports-topline-results-of-second-phase-3-trial-of-geographic-atrophy-drug-candidate
https://eyewire.news/tv/outlook-therapeutics-resubmits-bla-to-the-fda-for-investigational-wet-amd-drug
https://eyewire.news/tv/teva-receives-marketing-authorization-in-europe-for-lucentis-biosimilar-ranivisio